Mail-Order Genetic Screening
Recent years have seen a flood of studies linking genetic variations to particular diseases, and companies are trying to parlay those discoveries into direct-to-consumer genetic tests. Navigenics mails its subscribers containers for saliva samples. When it gets the samples back, it uses microarrays–chips studded with fragments of DNA–to screen the subscribers’ DNA for genetic variations linked to 18 diseases, including Alzheimer’s and colon cancer. Such genetic screening has received little clinical evaluation, however, so whether it helps prevent disease is unclear.
Credit: Joshua Scott
Product: Health Compass
Cost: $2,500 for the initial test; $250 a year for continued consultation
Source: www.navigenics.com
Company: Navigenics
Other products in this section:
Keep Reading
Most Popular
Large language models can do jaw-dropping things. But nobody knows exactly why.
And that's a problem. Figuring it out is one of the biggest scientific puzzles of our time and a crucial step towards controlling more powerful future models.
How scientists traced a mysterious covid case back to six toilets
When wastewater surveillance turns into a hunt for a single infected individual, the ethics get tricky.
The problem with plug-in hybrids? Their drivers.
Plug-in hybrids are often sold as a transition to EVs, but new data from Europe shows we’re still underestimating the emissions they produce.
Google DeepMind’s new generative model makes Super Mario–like games from scratch
Genie learns how to control games by watching hours and hours of video. It could help train next-gen robots too.
Stay connected
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.